| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.58B | 8.61B | 8.30B | 6.87B | 6.05B | 5.70B |
| Gross Profit | 3.05B | 2.87B | 2.60B | 2.13B | 2.15B | 1.98B |
| EBITDA | 1.23B | 1.14B | 1.05B | 661.00M | 854.00M | 702.00M |
| Net Income | 716.00M | 477.00M | 437.00M | 275.00M | 472.00M | 265.00M |
Balance Sheet | ||||||
| Total Assets | 10.34B | 11.14B | 10.68B | 10.32B | 9.55B | 9.26B |
| Cash, Cash Equivalents and Short-Term Investments | 339.00M | 953.00M | 658.00M | 583.00M | 692.00M | 396.00M |
| Total Debt | 1.64B | 2.51B | 2.48B | 2.48B | 2.37B | 2.48B |
| Total Liabilities | 4.77B | 5.71B | 5.58B | 5.32B | 5.03B | 5.08B |
| Stockholders Equity | 5.57B | 5.43B | 5.10B | 4.99B | 4.51B | 4.18B |
Cash Flow | ||||||
| Free Cash Flow | 794.00M | 602.00M | 496.00M | 305.00M | 664.00M | 366.00M |
| Operating Cash Flow | 940.00M | 765.00M | 778.00M | 519.00M | 858.00M | 656.00M |
| Investing Cash Flow | -133.00M | -91.00M | -280.00M | -213.00M | -191.00M | -289.00M |
| Financing Cash Flow | -1.20B | -367.00M | -379.00M | -406.00M | -436.00M | -476.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | kr12.03B | 16.59 | 12.72% | 2.74% | 0.81% | 57.02% | |
71 Outperform | kr5.03B | 15.38 | 9.65% | 4.83% | 3.79% | 39.15% | |
71 Outperform | kr3.20B | 18.55 | ― | 4.40% | 19.47% | 46.15% | |
68 Neutral | kr6.44B | 20.80 | ― | 2.56% | 7.37% | 2.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | kr3.50B | 79.43 | 0.87% | ― | 5.99% | -38.16% | |
58 Neutral | kr1.29B | -323.64 | -0.17% | 2.34% | -2.95% | -112.90% |
Cloetta AB reported a strong increase in profitability for the July-September 2025 quarter, driven by strategic focus on margin enhancement and cost control, despite a slight decline in net sales. The company is on track to meet its mid-term EBIT margin target of 12% by 2027, with notable growth in its Pick & mix segment and improved operating profits.
The most recent analyst rating on ($SE:CLA.B) stock is a Buy with a SEK41.00 price target. To see the full list of analyst forecasts on Cloetta AB stock, see the SE:CLA.B Stock Forecast page.